Follow
Stefan Sthl
Title
Cited by
Cited by
Year
Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support
T Hultman, S Stahl, E Homes, M Uhlen
Nucleic acids research 17 (13), 4937-4946, 1989
9041989
Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain
K Nord, E Gunneriusson, J Ringdahl, S Sthl, M Uhln, P Nygren
Nature biotechnology 15 (8), 772-777, 1997
8801997
Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications
J Lfblom, J Feldwisch, V Tolmachev, J Carlsson, S Sthl, FY Frejd
FEBS letters 584 (12), 2670-2680, 2010
6852010
Tumor imaging using a picomolar affinity HER2 binding affibody molecule
A Orlova, M Magnusson, TLJ Eriksson, M Nilsson, B Larsson, ...
Cancer research 66 (8), 4339-4348, 2006
5932006
Affinity fusion strategies for detection, purification, and immobilization of recombinant proteins
J Nilsson, S Sthl, J Lundeberg, M Uhln, P Nygren
Protein expression and purification 11 (1), 1-16, 1997
4731997
Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation
W Hoyer, C Grnwall, A Jonsson, S Sthl, T Hrd
Proceedings of the National Academy of Sciences 105 (13), 5099-5104, 2008
4562008
Specific binding of proinsulin C-peptide to human cell membranes
R Rigler, A Pramanik, P Jonasson, G Kratz, OT Jansson, P Nygren, ...
Proceedings of the National Academy of Sciences 96 (23), 13318-13323, 1999
4491999
Display of proteins on bacteria
P Samuelson, E Gunneriusson, P Nygren, S Sthl
Journal of biotechnology 96 (2), 129-154, 2002
3582002
Selection and characterization of HER2/neu-binding affibody ligands
M Wikman, AC Steffen, E Gunneriusson, V Tolmachev, GP Adams, ...
Protein Engineering Design and Selection 17 (5), 455-462, 2004
3452004
Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines
S Liljeqvist, S Sthl
Journal of biotechnology 73 (1), 1-33, 1999
2641999
Genetic design for facilitated production and recovery of recombinant proteins in Escherichia coli
P Jonasson, S Liljeqvist, PA Nygren, S Sthl
Biotechnology and applied biochemistry 35 (2), 91-105, 2002
2622002
Bacterial surface display: trends and progress
S Sthl, M Uhln
Trends in biotechnology 15 (5), 185-192, 1997
2551997
Engineering proteins to facilitate bioprocessing
P Nygren, S Stefan, M Uhln
Trends in biotechnology 12 (5), 184-188, 1994
2461994
Affibody molecules in biotechnological and medical applications
S Sthl, T Grslund, AE Karlstrm, FY Frejd, P Nygren, J Lfblom
Trends in biotechnology 35 (8), 691-712, 2017
2402017
Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule
M Friedman, A Orlova, E Johansson, TLJ Eriksson, I Hidn-Guthenberg, ...
Journal of molecular biology 376 (5), 1388-1402, 2008
1902008
Optimization of electroporation‐mediated transformation: Staphylococcus carnosus as model organism
J Lfblom, N Kronqvist, M Uhln, S Sthl, H Wernrus
Journal of applied microbiology 102 (3), 736-747, 2007
1652007
Engineered affinity proteins—generation and applications
C Grnwall, S Sthl
Journal of biotechnology 140 (3-4), 254-269, 2009
1622009
Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment
UF Power, H Plotnicky-Gilquin, T Huss, A Robert, M Trudel, S Sthl, ...
Virology 230 (2), 155-166, 1997
1611997
Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor
M Friedman, E Nordberg, I Hidn-Guthenberg, H Brismar, GP Adams, ...
Protein engineering, design & selection 20 (4), 189-199, 2007
1602007
Upstream strategies to minimize proteolytic degradation upon recombinant production inEscherichia coli
M Murby, M Uhln, S Sthl
Protein expression and purification 7 (2), 129-136, 1996
1591996
The system can't perform the operation now. Try again later.
Articles 1–20